Skeletal muscle insulin resistance: the interplay of local lipid excess and mitochondrial dysfunction

Metabolism: Clinical and Experimental

Volumn 59, Issue 1, 2010, Pages 70-85

  Chow, Lisa ^a   From, Arthur ^a   Seaquist, Elizabeth ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; CERAMIDE; DIACYLGLYCEROL; LIPID;

DISORDERS OF MITOCHONDRIAL FUNCTIONS; GLUCOSE TRANSPORT; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIPID DIET; LIPID METABOLISM; MUSCLE MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE;

ANIMALS; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL;

EID: 72049128291     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.07.009     Document Type: Review

References (201)

1. Lillioja S., Mott D.M., Spraul M., Ferraro R., Foley J.E., Ravussin E., et al. Insulin-resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes-mellitus-prospective studies of Pima-Indians. N Engl J Med 329 (1993) 1988-1992
2. Warram J.H., Martin B.C., Krolewski A.S., Soeldner J.S., and Kahn C.R. Slow glucose removal rate and hyperinsulinemia precede the development of type-II diabetes in the offspring of diabetic parents. Ann Intern Med 113 (1990) 909-915
3. Shulman G.I., Rothman D.L., Jue T., Stein P., Defronzo R.A., and Shulman R.G. Quantitation of muscle glycogen-synthesis in normal subjects and subjects with non-insulin-dependent diabetes by C-13 nuclear magnetic resonance spectroscopy. N Engl J Med 322 (1990) 223-228
4. Defronzo R.A., Jacot E., Jequier E., Maeder E., Wahren J., and Felber J.P. The effect of insulin on the disposal of intravenous glucose-results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes. 30 (1981) 1000-1007
5. Shulman G.I. Cellular mechanisms of insulin resistance. J Clin Invest 106 (2000) 171-176
6. Perseghin G., Scifo P., De Cobelli F., Pagliato E., Battezzati A., Arcelloni C., et al. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48 (1999) 1600-1606
7. Thamer C., Machann J., Bachmann O., Haap M., Dahl D., Wietek B., et al. Intramyocellular lipids: anthropometric determinants and relationships with maximal aerobic capacity and insulin sensitivity. J Clin Endocrinol Metab 88 (2003) 1785-1791
8. Petersen K.F., Dufour S., Befroy D., Garcia R., and Shulman G.I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350 (2004) 664-671
9. Boden G., Jadali F., White J., Liang Y., Mozzoli M., Chen X., et al. Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. J Clin Invest 88 (1991) 960-966
10. Boden G., and Chen X.H. Effects of fat on glucose-uptake and utilization in patients with non-insulin-dependent diabetes. J Clin Invest 96 (1995) 1261-1268
11. Asmann Y.W., Stump C.S., Short K.R., Coenen-Schimke J.M., Guo Z., Bigelow M.L., et al. Skeletal muscle mitochondrial functions, mitochondrial DNA copy numbers, and gene transcript profiles in type 2 diabetic and nondiabetic subjects at equal levels of low or high insulin and euglycemia. Diabetes 55 (2006) 3309-3319
12. Stump C.S., Short K.R., Bigelow M.L., Schimke J.M., and Nair K.S. Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts. Proc Natl Acad Sci U S A 100 (2003) 7996-8001
13. Patti M.E., Butte A.J., Crunkhorn S., Cusi K., Berria R., Kashyap S., et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A. 100 (2003) 8466-8471
14. Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes.[see comment]. Nat Genet 34 (2003) 267-273
15. Kelley D.E., He J., Menshikova E.V., and Ritov V.B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes. 51 (2002) 2944-2950
16. Kasuga M., Karlsson F.A., and Kahn C.R. Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor. Science 215 (1982) 185-187
17. Kasuga M., Zick Y., Blithe D.L., Crettaz M., and Kahn C.R. Insulin stimulates tyrosine phosphorylation of the insulin-receptor in a cell-free system. Nature 298 (1982) 667-669
18. Sun X.J., Rothenberg P., Kahn C.R., Backer J.M., Araki E., Wilden P.A., et al. Structure of the insulin-receptor substrate Irs-1 defines a unique signal transduction protein. Nature 352 (1991) 73-77
19. Araki E., Lipes M.A., Patti M.E., Bruning J.C., Haag B., Johnson R.S., et al. Alternative pathway of insulin signaling in mice with targeted disruption of the Irs-1 gene. Nature. 372 (1994) 186-190
20. White M.F. IRS proteins and the common path to diabetes. Am J Physiol-Endocrinol Metab 283 (2002) E413-E422
21. Okada T., Kawano Y., Sakakibara T., Hazeki O., and Ui M. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose-transport and antilipolysis in rat adipocytes-studies with a selective inhibitor wortmannin. J Biol Chem. 269 (1994) 3568-3573
22. Ruderman N.B., Kapeller R., White M.F., and Cantley L.C. Activation of phosphatidylinositol 3-kinase by insulin. Proc Natl Acad Sci U S A 87 (1990) 1411-1415
23. Backer J.M., Myers M.G., Shoelson S.E., Chin D.J., Sun X.J., Miralpeix M., et al. Phosphatidylinositol 3′-kinase is activated by association with Irs-1 during insulin stimulation. EMBO J 11 (1992) 3469-3479
24. Cheatham B., Vlahos C.J., Cheatham L., Wang L., Blenis J., and Kahn C.R. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of Pp70 S6 kinase, DNA-synthesis, and glucose-transporter translocation. Mol Cell Biol 14 (1994) 4902-4911
25. Frevert E.U., and Kahn B.B. Differential effects of constitutively active phosphatidylinositol 3-kinase on glucose transport, glycogen synthase activity, and DNA synthesis in 3T3-L1 adipocytes. Mol Cell Biol. 17 (1997) 190-198
26. Katagiri H., Asano T., Ishihara H., Inukai K., Shibasaki Y., Kikuchi M., et al. Overexpression of catalytic subunit p110 alpha of phosphatidylinositol 3-kinase increases glucose transport activity with translocation of glucose transporters in 3T3-L1 adipocytes. J Biol Chem. 271 (1996) 16987-16990
27. Tanti J.F., Gremeaux T., Grillo S., Calleja V., Klippel A., Williams L.T., et al. Overexpression of a constitutively active form of phosphatidylinositol 3-kinase is sufficient to promote glut 4 translocation in adipocytes. J Biol Chem. 271 (1996) 25227-25232
28. Kohn A.D., Summers S.A., Birnbaum M.J., and Roth R.A. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem. 271 (1996) 31372-31378
29. Standaert M.L., Galloway L., Karnam P., Bandyopadhyay G., Moscat J., and Farese R.V. Protein kinase C-zeta as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes-potential role in glucose transport. J Biol Chem. 272 (1997) 30075-30082
30. Kotani K., Ogawa W., Matsumoto M., Kitamura T., Sakaue H., Hino Y., et al. Requirement of atypical protein kinase C lambda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes. Mol Cell Biol. 18 (1998) 6971-6982
31. Zisman A., Peroni O.D., Abel E.D., Michael M.D., Mauvais-Jarvis F., Lowell B.B., et al. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med. 6 (2000) 924-928
32. Thirone A.C.P., Carvalheira J.B.C., Hirata A.E., Velloso L.A., and Saad M.J.A. Regulation of Cbl-associated protein/Cbl pathway in muscle and adipose tissues of two animal models of insulin resistance. Endocrinology. 145 (2004) 281-293
33. Wadley G.D., Bruce C.R., Konstantopoulos N., Macaulay S.L., Howlett K.F., Hawley J.A., et al. The effect of insulin and exercise on c-Cbl protein abundance and phosphorylation in insulin-resistant skeletal muscle in lean and obese Zucker rats. Diabetologia. 47 (2004) 412-419
34. Somwar R., Perreault M., Kapur S., Taha C., Sweeney G., Ramlal T., et al. Activation of p38 mitogen-activated protein kinase alpha and beta by insulin and contraction in rat skeletal muscle-potential role in the stimulation of glucose transport. Diabetes. 49 (2000) 1794-1800
35. Goodyear L.J., Chang P.Y., Sherwood D.J., Dufresne S.D., and Moller D.E. Effects of exercise and insulin on mitogen-activated protein kinase signaling pathways in rat skeletal muscle. Am J Physiol-Endocrinol Metab 271 (1996) E403-E408
36. Ojuka E.O., Jones T.E., Nolte L.A., Chen M., Wamhoff B.R., Sturek M., et al. Regulation of GLUT4 biogenesis in muscle: evidence for involvement of AMPK and Ca2+. Am J Physiol-Endocrinol Metab 282 (2002) E1008-E1013
37. Wright D.C., Hucker K.A., Holloszy J.O., and Han D.H. Ca2+ and AMPK both mediate stimulation of glucose transport by muscle contractions. Diabetes. 53 (2004) 330-335
38. Hayashi T., Hirshman M.F., Kurth E.J., Winder W.W., and Goodyear L.J. Evidence for 5 ' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes. 47 (1998) 1369-1373
39. Sakamoto K., McCarthy A., Smith D., Green K.A., Hardie D.G., Ashworth A., et al. Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction. EMBO J 24 (2005) 1810-1820
40. McGee S.L., and Hargreaves M. Exercise and myocyte enhancer factor 2 regulation in human skeletal muscle. Diabetes. 53 (2004) 1208-1214
41. Treebak J.T., Glund S., Deshmukh A., Klein D.K., Long Y.C., Jensen T.E., et al. AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits. Diabetes. 55 (2006) 2051-2058
42. Kramer H.F., Witczak C.A., Taylor E.B., Fujii N., Hirshman M.F., and Goodyear L.J. AS160 regulates insulin- and contraction-stimulated glucose uptake in mouse skeletal muscle. J Biol Chem. 281 (2006) 31478-31485
43. Bruss M.D., Arias E.B., Lienhard G.E., and Cartee G.D. Increased phosphorylation of Akt substrate of 160 kDa (AS160) in rat skeletal muscle in response to insulin or contractile activity. Diabetes. 54 (2005) 41-50
44. Jakobsen S.N., Hardie D.G., Morrice N., and Tornqvist H.E. 5'-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside. J Biol Chem. 276 (2001) 46912-46916
45. Inoki K., Zhu T.Q., and Guan K.L. TSC2 mediates cellular energy response to control cell growth and survival. Cell. 115 (2003) 577-590
46. Shah O.J., Wang Z.Y., and Hunter T. Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Curr Biol. 14 (2004) 1650-1656
47. Harrington L.S., Findlay G.M., Gray A., Tolkacheva T., Wigfield S., Rebholz H., et al. The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J Cell Biol 166 (2004) 213-223
48. Cusi K., Maezono K., Osman A., Pendergrass M., Patti M.E., Pratipanawatr T., et al. Insulin resistance differentially affects the PI3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest 105 (2000) 311-320
49. Goodyear L.J., Giorgino F., Sherman L.A., Carey J., Smith R.J., and Dohm G.L. Insulin-receptor phosphorylation, insulin-receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest. 95 (1995) 2195-2204
50. Bjornholm M., Kawano Y., Lehtihet M., and Zierath J.R. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes. 46 (1997) 524-527
51. Paz K., Hemi R., LeRoith D., Karasik A., Elhanany E., Kanety H., et al. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem. 272 (1997) 29911-29918
52. Gao Z.G., Hwang D., Bataille F., Lefevre M., York D., Quon M., et al. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J Biol Chem. 277 (2002) 48115-48121
53. Hirosumi J., Tuncman G., Chang L.F., Gorgun C.Z., Uysal K.T., Maeda K., et al. A central role for JNK in obesity and insulin resistance. Nature. 420 (2002) 333-336
54. Aguirre V., Uchida T., Yenush L., Davis R., and White M.F. The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem. 275 (2000) 9047-9054
55. Li J.P., DeFea K., and Roth R.A. Modulation of insulin receptor substrate-1 tyrosine phosphorylation by an Akt/phosphatidylinositol 3-kinase pathway. J Biol Chem. 274 (1999) 9351-9356
56. Ozes O.N., Akca H., Mayo L.D., Gustin J.A., Maehama T., Dixon J.E., et al. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc Natl Acad Sci U S A. 98 (2001) 4640-4645
57. Ravichandran L.V., Esposito D.L., Chen J., and Quon M.J. Protein kinase C-zeta phosphorylates insulin receptor substrate-1 and impairs its ability to activate phosphatidylinositol 3-kinase in response to insulin. J Biol Chem. 276 (2001) 3543-3549
58. Yu C., Chen Y., Cline G.W., Zhang D., Zong H., Wang Y., et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem. 277 (2002) 50230-50236
59. Kim Y.B., Kotani K., Ciaraldi T.P., Henry R.R., and Kahn B.B. Insulin-stimulated protein kinase C lambda/zeta activity is reduced in skeletal muscle of humans with obesity and type 2 diabetes-reversal with weight reduction. Diabetes. 52 (2003) 1935-1942
60. Vollenweider P., Menard B., and Nicod P. Insulin resistance, defective insulin receptor substrate 2-associated phosphatidylinositol-3 ' kinase activation, and impaired atypical protein kinase C (zeta/lambda) activation in myotubes from obese patients with impaired glucose tolerance. Diabetes. 51 (2002) 1052-1059
61. Beeson M., Sajan M.P., Dizon M., Grebenev D., Gomez-Daspet J., Miura A., et al. Activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4) is defective in muscle in type 2 diabetes and impaired glucose tolerance-amelioration by rosiglitazone and exercise. Diabetes. 52 (2003) 1926-1934
62. Kim Y.B., Nikoulina S.E., Ciaraldi T.P., Henry R.R., and Kahn B.B. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. J Clin Invest. 104 (1999) 733-741
63. Kruszynska Y.T., Worrall D.S., Ofrecio J., Frias J.P., Macaraeg G., and Olefsky J.M. Fatty acid-induced insulin resistance: decreased muscle PI3K activation but unchanged Akt phosphorylation. J Clin Endocrinol Metab. 87 (2002) 226-234
64. Krook A., Roth R.A., Jiang X.J., Zierath J.R., and Wallberg-Henriksson H. Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects. Diabetes. 47 (1998) 1281-1286
65. Burgering B.M.T., and Coffer P.J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature. 376 (1995) 599-602
66. Farese R.V. Function and dysfunction of aPKC isoforms for glucose transport in insulin-sensitive and insulin-resistant states. Am J Physiol-Endocrinol Metab 283 (2002) E1-E11
67. Shepherd P.R., and Kahn B.B. Mechanisms of disease-glucose transporters and insulin action-implications for insulin resistance and diabetes mellitus. N Engl J Med 341 (1999) 248-257
68. Leng Y., Steiler T.L., and Zierath J.R. Effects of insulin, contraction, and phorbol esters on mitogen-activated protein kinase signaling in skeletal muscle from lean and ob/ob mice. Diabetes. 53 (2004) 1436-1444
69. Wolfe R.R., Peters E.J., Klein S., Holland O.B., Rosenblatt J., and Gary H. Effect of short-term fasting on lipolytic responsiveness in normal and obese human subjects. Am J Physiol 252 (1987) E189-E196
70. Jensen M.D., Haymond M.W., Rizza R.A., Cryer P.E., and Miles J.M. Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest. 83 (1989) 1168-1173
71. Dobbins R.L., Chester M.M., Daniels M.B., McGarry J.D., and Stein D.T. Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans. Diabetes. 47 (1998) 1613-1618
72. Baldeweg S.E., Golay A., Natali A., Balkau B., Del Prato S., and Coppack S.W. Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. Eur J Clin Invest. 30 (2000) 45-52
73. Reaven G.M., Hollenbeck C., Jeng C.Y., Wu M.S., and Chen Y.D.I. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes. 37 (1988) 1020-1024
74. Pan D.A., Lillioja S., Kriketos A.D., Milner M.R., Baur L.A., Bogardus C., et al. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46 (1997) 983-988
75. Brechtel K., Dahl D.B., Machann J., Bachmann O.P., Wenzel I., Maier T., et al. Fast elevation of the intramyocellular lipid content in the presence of circulating free fatty acids and hyperinsulinemia: a dynamic H-1-MRS study. Magn Reson Med 45 (2001) 179-183
76. Bachmann O.P., Dahl D.B., Brechtel K., Machann J., Haap M., Maier T., et al. Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes. 50 (2001) 2579-2584
77. Boden G., Jadali F., White J., Liang Y., Mozzoli M., Chen X., et al. Effects of fat on insulin-stimulated carbohydrate-metabolism in normal men. J Clin Invest. 88 (1991) 960-966
78. Belfort R., Mandarino L., Kashyap S., Wirfel K., Pratipanawatr T., Berria R., et al. Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes. 54 (2005) 1640-1648
79. Itani S.I., Ruderman N.B., Schmieder F., and Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes. 51 (2002) 2005-2011
80. Griffin M.E., Marcucci M.J., Cline G.W., Bell K., Barucci N., Lee D., et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes. 48 (1999) 1270-1274
81. Kim J.K., Kim Y.J., Fillmore J.J., Chen Y., Moore I., Lee J.S., et al. Prevention of fat-induced insulin resistance by salicylate. J Clin Invest. 108 (2001) 437-446
82. Oakes N.D., Cooney G.J., Camilleri S., Chisholm D.J., and Kraegen E.W. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes. 46 (1997) 1768-1774
83. Storlien L.H., James D.E., Burleigh K.M., Chisholm D.J., and Kraegen E.W. Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats. Am J Physiol 251 (1986) E576-E583
84. Fasching P., Ratheiser K., Schneeweiss B., Rohac M., Nowotny P., and Waldhausl W. No effect of short-term dietary supplementation of saturated and poly- and monounsaturated fatty acids on insulin secretion and sensitivity in healthy men. Ann Nutr Metab 40 (1996) 116-122
85. Schwab U.S., Niskanen L.K., Maliranta H.M., Savolainen M.J., Kesaniemi Y.A., and Uusitupa M.I.J. Lauric and palmitic acid-enriched diets have minimal impact on serum lipid and lipoprotein concentrations and glucose metabolism in healthy young women. J Nutr 125 (1995) 466-473
86. Borkman M., Campbell L.V., Chisholm D.J., and Storlien L.H. Comparison of the effects on insulin sensitivity of high-carbohydrate and high-fat diets in normal subjects. J Clin Endocrinol Metab. 72 (1991) 432-437
87. Bisschop P.H., de Metz J., Ackermans M.T., Endert E., Pijl H., Kuipers F., et al. Dietary fat content alters insulin-mediated glucose metabolism in healthy men. Am J Clin Nutr 73 (2001) 554-559
88. Vessby B., Uusitupa M., Hermansen K., Riccardi G., Rivellese A.A., Tapsell L.C., et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU study. Diabetologia. 44 (2001) 312-319
89. Esposito K., Marfella R., Ciotola M., Di Palo C., Giugliano F., Giugliano G., et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome-a randomized trial. JAMA 292 (2004) 1440-1446
90. Martinez-Gonzalez M.A., de la Fuente-Arrillaga C., Nunez-Cordoba J.M., Basterra-Gortari F.J., Beunza J.J., Vazquez Z., et al. Adherence to Mediterranean diet and risk of developing diabetes: prospective cohort study. Br Med J 336 (2008) 1348-1351
91. Marshall J.A., Bessesen D.H., and Hamman R.F. High saturated fat and low starch and fibre are associated with hyperinsulinaemia in a non-diabetic population: the San Luis Valley Diabetes Study. Diabetologia. 40 (1997) 430-438
92. Goodpaster B.H., He J., Watkins S., and Kelley D.E. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 86 (2001) 5755-5761
93. Kim J.K., Fillmore J.J., Chen Y., Yu C.L., Moore I.K., Pypaert M., et al. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci U S A. 98 (2001) 7522-7527
94. Liu L., Zhang Y., Chen N., Shi X., Tsang B., and Yu Y.H. Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. J Clin Invest 117 (2007) 1679-1689
95. Russell A.P., Gastaldi G., Bobbioni-Harsch E., Arboit P., Gobelet C., Deriaz O., et al. Lipid peroxidation in skeletal muscle of obese as compared to endurance-trained humans: a case of good vs. bad lipids?. Febs Letters. 551 (2003) 104-106
96. Summers S.A. Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 45 (2006) 42-72
97. Laybutt D.R., Schmitz-Peiffer C., Saha A.K., Ruderman N.B., Biden T.J., and Kraegen E.W. Muscle lipid accumulation and protein kinase C activation in the insulin-resistant chronically glucose-infused rat. Am J Physiol-Endocrinol Metab 277 (1999) E1070-E1076
98. Esterbauer H., Schaur R.J., and Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11 (1991) 81-128
99. Mogensen M., Sahlin K., Fernstrom M., Glintborg D., Vind B.F., Beck-Nielsen H., et al. Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes. 56 (2007) 1592-1599
100. Straczkowski M., Kowalska I., Baranowski M., Nikolajuk A., Otziomek E., Zabielski P., et al. Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes. Diabetologia. 50 (2007) 2366-2373
101. Dube J.J., Amati F., Stefanovic-Racic M., Toledo F.G.S., Sauers S.E., and Goodpaster B.H. Exercise-induced alterations in intramyocellular lipids and insulin resistance: the athlete's paradox revisited. Am J Physiol-Endocrinol Metab 294 (2008) E882-E888
102. Bruce C.R., Thrush A.B., Mertz V.A., Bezaire V., Chabowski A., Heigenhauser G.J.F., et al. Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content. Am J Physiol-Endocrinol Metab 291 (2006) E99-E107
103. Merrill A.H. De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway. J Biol Chem. 277 (2002) 25843-25846
104. Adams II J.M., Pratipanawatr T., Berria R., Wang E., DeFronzo R.A., Sullards M.C., et al. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes. 53 (2004) 25-31
105. Straczkowski M., Kowalska I., Nikolajuk A., Dzienis-Straczkowska S., Kinalska I., Baranowski M., et al. Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle. Diabetes. 53 (2004) 1215-1221
106. Serlie M.J., Meijer A.J., Groener J.E., Duran M., Endert E., Fliers E., et al. Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjects. J Clin Endocrinol Metab. 92 (2007) 1524-1529
107. Schmitz-Peiffer C., Craig D.L., and Biden T.J. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. The J Biol Chem. 274 (1999) 24202-24210
108. Kanety H., Hemi P., Papa M.Z., and Karasik A. Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1. J Biol Chem. 271 (1996) 9895-9897
109. Manco M., Mingrone G., Greco A.V., Capristo E., Gniuli D., De Gaetano A., et al. Insulin resistance directly correlates with increased saturated fatty acids in skeletal muscle triglycerides. Metab: Clin Exp 49 (2000) 220-224
110. Ellis B.A., Poynten A., Lowy A.J., Furler S.M., Chisholm D.J., Kraegen E.W., et al. Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am J Physiol-Endocrinol Metab 279 (2000) E554-E560
111. Chen M.T., Kaufman L.N., Spennetta T., and Shrago E. Effects of high fat feeding to rats on the interrelationship of body weight, plasma insulin, and fatty acyl-coenzyme A esters in liver and skeletal muscle. Metab-Clin Exp 41 (1992) 564-569
112. Chavez J.A., and Summers S.A. Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2Cl2 myotubes. Arch Biochem Biophys 419 (2003) 101-109
113. Bajaj M., Suraamornkul S., Romanelli A., Cline G.W., Mandarino L.J., Shulman G.I., et al. Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty acyl-CoAs and insulin action in type 2 diabetic patients. Diabetes. 54 (2005) 3148-3153
114. Williams R.S. Mitochondrial gene expression in mammalian striated muscle-evidence that variation in gene dosage is the major regulatory event. J Biol Chem. 261 (1986) 2390-2394
115. Menshikova E., Ritov V., Ferrell R., Azuma K., Goodpaster B., and Kelley D. Characteristics of skeletal muscle mitochondrial biogenesis induced by moderate-intensity exercise and weight loss in obesity. J Appl Physiol 103 (2007) 21-27
116. Schaffer J.E., and Lodish H.F. Expression cloning and characterization of a novel adipocyte long-chain fatty-acid transport protein. Cell. 79 (1994) 427-436
117. McGarry J.D., and Brown N.F. The mitochondrial carnitine palmitoyltransferase system-from concept to molecular analysis. Eur J Biochem. 244 (1997) 1-14
118. Helge J.W., and Kiens B. Muscle enzyme activity in humans: role of substrate availability and training. Am J Physiol-Regul Integr Comp Physiol 41 (1997) R1620-R1624
119. Holloszy J.O., and Coyle E.F. Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. J Appl Physiol 56 (1984) 831-838
120. Boushel R., Gnaiger E., Schjerling P., Skovbro M., Kraunsoe R., and Dela F. Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia. 50 (2007) 790-796
121. Kim J.Y., Hickner R.C., Cortright R.L., Dohm G.L., and Houmard J.A. Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol-Endocrinol Metab 279 (2000) E1039-E1044
122. Ukropcova B., McNeil M., Sereda O., de Jonge L., Xie H., Bray G.A., et al. Dynamic changes in fat oxidation in human primary myocytes mirror metabolic characteristics of the donor. J Clin Invest. 115 (2005) 1934-1941
123. Petersen K.F., Befroy D., Dufour S., Dziura J., Ariyan C., Rothman D.L., et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science. 300 (2003) 1140-1142
124. Schrauwen-Hinderling V.B., Kooi M.E., Hesselink M.K.C., Jeneson J.A.L., Backes W.H., van Echteld C.J.A., et al. Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects. Diabetologia. 50 (2007) 113-120
125. De Feyter H.M., van den Broek N.M.A., Praet S.F.E., Nicolay K., van Loon L.J.C., and Prompers J.J. Early or advanced stage type 2 diabetes is not accompanied by in vivo skeletal muscle mitochondrial dysfunction. Eur J Endocrinol. 158 (2008) 643-653
126. Lebon V., Dufour S., Petersen K.F., Ren J.M., Jucker B.M., Slezak L.A., et al. Effect of triiodothyronine on mitochondrial energy coupling in human skeletal muscle. J Clin Invest. 108 (2001) 733-737
127. Befroy D.E., Petersen K.F., Dufour S., Mason G.F., de Graaf R.A., Rothman D.L., et al. Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients. Diabetes. 56 (2007) 1376-1381
128. Puigserver P., Wu Z.D., Park C.W., Graves R., Wright M., and Spiegelman B.M. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell. 92 (1998) 829-839
129. Wu Z.D., Puigserver P., Andersson U., Zhang C.Y., Adelmant G., Mootha V., et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell. 98 (1999) 115-124
130. Larsson N.G., Wang J.M., Wilhelmsson H., Oldfors A., Rustin P., Lewandoski M., et al. Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet 18 (1998) 231-236
131. Zong H.H., Ren J.M., Young L.H., Pypaert M., Mu J., Birnbaum M.J., et al. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc Natl Acad Sci U S A. 99 (2002) 15983-15987
132. Winder W.W., Holmes B.F., Rubink D.S., Jensen E.B., Chen M., and Holloszy J.O. Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J Appl Physiol 88 (2000) 2219-2226
133. Echtay K.S., Roussel D., St-Pierre J., Jekabsons M.B., Cadenas S., Stuart J.A., et al. Superoxide activates mitochondrial uncoupling proteins. Nature. 415 (2002) 96-99
134. Heaton G.M., Wagenvoord R.J., Kemp A., and Nicholls D.G. Brown adipose tissue mitochondria: photoaffinity labeling of regulatory site of energy dissipation. Eur J Biochem. 82 (1978) 515-521
135. Fleury C., Neverova M., Collins S., Raimbault S., Champigny O., LeviMeyrueis C., et al. Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 15 (1997) 269-272
136. Boss O., Samec S., Paoloni-Giacobino A., Rossier C., Dulloo A., Seydoux J., et al. Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett 408 (1997) 39-42
137. Szendroedi J., Schmid A.I., Chmelik M., Toth C., Brehm A., Krssak M., et al. Muscle mitochondrial ATP synthesis and glucose transport/phosphorylation in type 2 diabetes. Plos Med 4 (2007) 858-867
138. Kelley D.E., and Mandarino L.J. Fuel selection in human skeletal muscle in insulin resistance-a reexamination. Diabetes. 49 (2000) 677-683
139. Ukropcova B., Sereda O., de Jonge L., Bogacka I., Nguyen T., Xie H., et al. Family history of diabetes links impaired substrate switching and reduced mitochondrial content in skeletal muscle. Diabetes. 56 (2007) 720-727
140. Morino K., Petersen K.F., Dufour S., Befroy D., Frattini J., Shatzkes N., et al. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J Clin Invest. 115 (2005) 3587-3593
141. Nair K.S., Bigelow M.L., Asmann Y.W., Chow L.S., Coenen-Schimke J.M., Klaus K.A., et al. Asian Indians have enhanced skeletal muscle mitochondrial capacity to produce ATP in association with severe insulin resistance. Diabetes. 57 (2008) 1166-1175
142. De Feyter H.M., Lenaers E., Houten S.M., Schrauwen P., Hesselink M.K., Wanders R.J.A., et al. Increased intramyocellular lipid content but normal skeletal muscle mitochondrial oxidative capacity throughout the pathogenesis of type 2 diabetes. FASEB J 22 (2008) 3947-3955
143. Zhang D.Y., Liu Z.X., Choi C.S., Tian L.Q., Kibbey R., Dong J.Y., et al. Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance. Proc Natl Acad Sci U S A. 104 (2007) 17075-17080
144. Handschin C., Choi C.S., Chin S., Kim S., Kawamori D., Kurpad A.J., et al. Abnormal glucose homeostasis in skeletal muscle-specific PGC-1 alpha knockout mice reveals skeletal muscle-pancreatic beta cell crosstalk. J Clin Invest. 117 (2007) 3463-3474
145. Pospisilik J.A., Knauf C., Joza N., Benit P., Orthofer M., Cani P.D., et al. Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell. 131 (2007) 476-491
146. Abdul-Ghani M.A., Muller F.L., Liu Y.H., Chavez A.O., Balas B., Zuo P.G., et al. Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance. Am J Physiol-Endocrinol Metab 295 (2008) E678-E685
147. Randle P.J., Garland P.B., Hales C.N., Newsholme E.A., Randle P.J., Garland P.B., et al. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1 (1963) 785-789
148. Tsintzas K., Chokkalingam K., Jewell K., Norton L., Macdonald I.A., and Constantin-Teodosiu D. Elevated free fatty acids attenuate the insulin-induced suppression of PDK4 gene expression in human skeletal muscle: potential role of intramuscular long-chain acyl-coenzyme a. J Clin Endocrinol Metab. 92 (2007) 3967-3972
149. Brehm A., Krssak M., Schmid A.I., Nowotny P., Waldhausl W., and Roden M. Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle. Diabetes. 55 (2006) 136-140
150. Hoeks J., Hesselink M.K.C., Russell A.P., Mensink M., Saris W.H.M., Mensink R.P., et al. Peroxisome proliferator-activated receptor-gamma coactivator-1 and insulin resistance: acute effect of fatty acids. Diabetologia. 49 (2006) 2419-2426
151. Tunstall R.J., and Cameron-Smith D. Effect of elevated lipid concentrations on human skeletal muscle gene expression. Metab-Clin Exp 54 (2005) 952-959
152. Ling C., Poulsen P., Carlsson E., Ridderstrale M., Almgren P., Wojtaszewski J., et al. Multiple environmental and genetic factors influence skeletal muscle PGC-1 alpha and PGC-1 beta gene expression in twins. J Clin Invest. 114 (2004) 1518-1526
153. Richardson D.K., Kashyap S., Bajaj M., Cusi K., Mandarino S.J., Finlayson J., et al. Lipid infusion decreases the expression of nuclear encoded mitochondrial genes and increases the expression of extracellular matrix genes in human skeletal muscle. J Biol Chem. 280 (2005) 10290-10297
154. Heilbronn L.K., Gregersen S., Shirkhedkar D., Hu D., and Campbell L.V. Impaired fat oxidation after a single high-fat meal in insulin-sensitive nondiabetic individuals with a family history of type 2 diabetes. Diabetes. 56 (2007) 2046-2053
155. Sparks L.M., Xie H., Koza R.A., Mynatt R., Hulver M.W., Bray G.A., et al. A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes. 54 (2005) 1926-1933
156. Goedecke J.H., Christie C., Wilson G., Dennis S.C., Noakes T.D., Hopkins W.G., et al. Metabolic adaptations to a high-fat diet in endurance cyclists. Metab: Clin Exp 48 (1999) 1509-1517
157. Vogt M., Puntschart A., Howald H., Mueller B., Mannhart C., Gfeller-Tuescher L., et al. Effects of dietary fat on muscle substrates, metabolism, and performance in athletes. Med and Sci Sports Exerc 35 (2003) 952-960
158. Iossa S., Mollica M.P., Lionetti L., Crescenzo R., Botta M., and Liverini G. Skeletal muscle oxidative capacity in rats fed high-fat diet. Int J Obes 26 (2002) 65-72
159. Turner N., Bruce C.R., Beale S.M., Hoehn K.L., So T., Rolph M.S., et al. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle-evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes. 56 (2007) 2085-2092
160. Chanseaume E., Giraudet C., Gryson C., Walrand S., Rousset P., Boirie Y., et al. Enhanced muscle mixed and mitochondrial protein synthesis rates after a high-fat or high-sucrose diet. Obesity. 15 (2007) 853-859
161. Obici S., Wang J.L., Chowdury R., Feng Z.H., Siddhanta U., Morgan K., et al. Identification of a biochemical link between energy intake and energy expenditure. J Clin Invest. 109 (2002) 1599-1605
162. Bonnard C., Durand A., Peyrol S., Chanseaume E., Chauvin M.A., Morio B., et al. Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J Clin Invest. 118 (2008) 789-800
163. Miller W.C., Bryce G.R., and Conlee R.K. Adaptations to a high-fat diet that increase exercise endurance in male rats. J Appl Physiol 56 (1984) 78-83
164. Sreekumar R., Unnikrishnan J., Fu A., Nygren J., Short K.R., Schimke J., et al. Impact of high-fat diet and antioxidant supplement on mitochondrial functions and gene transcripts in rat muscle. Am J Physiol-Endocrinol Metab 282 (2002) E1055-E1061
165. Chanseaume E., Tardy A.L., Salles J., Giraudet C., Rousset P., Tissandier A., et al. Chronological approach of diet-induced alterations in muscle mitochondrial functions in rats. Obesity. 15 (2007) 50-59
166. Garcia-Roves P., Huss J.M., Han D.H., Hancock C.R., Iglesias-Gutierrez E., Chen M., et al. Raising plasma fatty acid concentration induces increased biogenesis of mitochondria in skeletal muscle. Proc Natl Acad Sci U S A. 104 (2007) 10709-10713
167. Ruderman N.B., Saha A.K., Vavvas D., and Witters L.A. Malonyl-CoA, fuel sensing, and insulin resistance. Am J Physiol-Endocrinol Metab 276 (1999) E1-E18
168. Koves T.R., Li P., An J., Akimoto T., Slentz D., Ilkayeva O., et al. Peroxisome proliferator-activated receptor-gamma co-activator 1 alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J Biol Chem. 280 (2005) 33588-33598
169. Dobbins R.L., Szczepaniak L.S., Bentley B., Esser V., Myhill J., and McGarry J.D. Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats. Diabetes. 50 (2001) 123-130
170. Koves T.R., Ussher J.R., Noland R.C., Slentz D., Mosedale M., Ilkayeva O., et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 7 (2008) 45-56
171. Houstis N., Rosen E.D., and Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 440 (2006) 944-948
172. Turrens J.F. Superoxide production by the mitochondrial respiratory chain. Biosci Rep 17 (1997) 3-8
173. Esposito L.A., Melov S., Panov A., Cottrell B.A., and Wallace D.C. Mitochondrial disease in mouse results in increased oxidative stress. Proc Natl Acad Sci U S A 96 (1999) 4820-4825
174. Finkel T., and Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature. 408 (2000) 239-247
175. Li Y.B., Huang T.T., Carlson E.J., Melov S., Ursell P.C., Olson T.L., et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 11 (1995) 376-381
176. Conniff M.E., James F.D., Huang T.T., and Wasserman D.H. Reduction in Mn-superoxide dismutase (SOD2) corrects insulin resistance due to high fat feeding in oxidative tissues of mice. FASEB J 22 (2008) 1226-1244
177. Echtay K.S. Mitochondrial uncoupling proteins-what is their physiological role?. Free Radic Biol Med 43 (2007) 1351-1371
178. VidalPuig A., Solanes G., Grujic D., Flier J.S., and Lowell B.B. UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue. Biochemical Biophys Res Commun 235 (1997) 79-82
179. Schrauwen P., Hoeks J., Schaart G., Kornips E., Binas B., van de Vusse G.J., et al. Uncoupling protein 3 as a mitochondrial fatty acid anion exporter. FASEB J 17 (2003) 2272-2274
180. Himms-Hagen J., and Harper M.E. Physiological role of UCP3 may be export of fatty acids from mitochondria when fatty acid oxidation predominates: an hypothesis. Exp Biol Med 226 (2001) 78-84
181. Goglia F., and Skulachev V.P. A function for novel uncoupling proteins: antioxidant defense of mitochondrial matrix by translocating fatty acid peroxides from the inner to the outer membrane leaflet. FASEB J 17 (2003) 1585-1591
182. Echtay K.S., Esteves T.C., Pakay J.L., Jekabsons M.B., Lambert A.J., Portero-Otin M., et al. A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. EMBO J 22 (2003) 4103-4110
183. Millet L., Vidal H., Andreelli F., Larrouy D., Riou J.P., Ricquier D., et al. Increased uncoupling protein-2 and -3 mRNA expression during fasting in obese and lean humans. J Clin Invest. 100 (1997) 2665-2670
184. Bao S., Kennedy A., Wojciechowski B., Wallace P., Ganaway E., and Garvey W.T. Expression of mRNAs encoding uncoupling proteins in human skeletal muscle-effects of obesity and diabetes. Diabetes. 47 (1998) 1935-1940
185. Vidal H., Langin D., Andreelli F., Millet L., Larrouy D., and Laville M. Lack of skeletal muscle uncoupling protein 2 and 3 mRNA induction during fasting in type-2 diabetic subjects. Am J Physiol-Endocrinol Metab 277 (1999) E830-E837
186. Krook A., Digby J., O'Rahilly S., Zierath J.R., and Wallberg-Henriksson H. Uncoupling protein 3 is reduced in skeletal muscle of NIDDM patients. Diabetes. 47 (1998) 1528-1531
187. Schrauwen P., Mensink M., Schaart G., Moonen-Kornips E., Sels J.P., Blaak E.E., et al. Reduced skeletal muscle uncoupling protein-3 content in prediabetic subjects and type 2 diabetic patients: restoration by rosiglitazone treatment. J Clin Endocrinol Metab 91 (2006) 1520-1525
188. Vidal-Puig A.J., Grujic D., Zhang C.Y., Hagen T., Boss O., Ido Y., et al. Energy metabolism in uncoupling protein 3 gene knockout mice. J Biol Chem. 275 (2000) 16258-16266
189. Gong D.W., Monemdjou S., Gavrilova O., Leon L.R., Marcus-Samuels B., Chou C.J., et al. Lack of obesity and normal response to fasting and thyroid hormone in mice lacking uncoupling protein-3. J Biol Chem. 275 (2000) 16251-16257
190. Cline G.W., Vidal-Puig A.J., Dufour S., Cadman K.S., Lowell B.B., and Shulman G.I. In vivo effects of uncoupling protein-3 gene disruption on mitochondrial energy metabolism. J Biol Chem. 276 (2001) 20240-20244
191. Brand M.D., Pamplona R., Portero-Otin M., Requena J.R., Roebuck S.J., Buckingham J.A., et al. Oxidative damage and phospholipid fatty acyl composition in skeletal muscle mitochondria from mice underexpressing or overexpressing uncoupling protein 3. Biochemical Journal. 368 (2002) 597-603
192. Li B., Nolte L.A., Ju J.S., Han D.H., Coleman T., Holloszy J.O., et al. Skeletal muscle respiratory uncoupling prevents diet-induced obesity and insulin resistance in mice. Nat Med. 6 (2000) 1115-1120
193. Clapham J.C., Arch J.R.S., Chapman H., Haynes A., Lister C., Moore G.B.T., et al. Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean. Nature. 406 (2000) 415-418
194. Choi C.S., Fillmore J.J., Kim J.K., Liu Z.X., Kim S., Collier E.F., et al. Overexpression of uncoupling protein 3 in skeletal muscle protects against fat-induced insulin resistance. J Clin Invest 117 (2007) 1995-2003
195. MacLellan J.D., Gerrits M.F., Gowing A., Smith P.J.S., Wheeler M.B., and Harper M.E. Physiological increases in uncoupling protein 3 augment fatty acid oxidation and decrease reactive oxygen species production without uncoupling respiration in muscle cells. Diabetes. 54 (2005) 2343-2350
196. Duval C., Camara Y., Hondares E., Sibille B., and Villarroya F. Overexpression of mitochondrial uncoupling protein-3 does not decrease production of the reactive oxygen species, elevated by palmitate in skeletal muscle cells. FEBS Lett 581 (2007) 955-961
197. Wang H., Knaub L.A., Jensen D.R., Young Jung D., Hong E.G., Ko H.J., et al. Skeletal muscle-specific deletion of lipoprotein lipase enhances insulin signaling in skeletal muscle but causes insulin resistance in liver and other tissues. Diabetes 58 (2009) 116-124
198. Abel E.D., Peroni O., Kim J.K., Kim Y.B., Boss O., Hadro E., et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature. 409 (2001) 729-733
199. Yang Q., Graham T.E., Mody N., Preitner F., Peroni O.D., Zabolotny J.M., et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 436 (2005) 356-362
200. Ozcan U., Cao Q., Yilmaz E., Lee A.H., Iwakoshi N.N., Ozdelen E., et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science. 306 (2004) 457-461
201. Ozcan U., Yilmaz E., Ozcan L., Furuhashi M., Vaillancourt E., Smith R.O., et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science. 313 (2006) 1137-1140